Rua Bioscience first NZX IPO of the year

Rua Bioscience first NZX IPO of the year
Brent Melville
Rua Bioscience chair Trevor Burt says the pharmaceutical grade cannabis firm will seek to raise $20 million via a listing on the NZX on Oct. 22 in the first initial public offering of the year. The East Coast based firm - an early recipient for a commercial medicinal production licence - will sell up to 40 million shares at 50 cents a share, representing 28.6 percent of the company in what will be the NZX's first IPO since Napier Port listed last year and the second cannabis firm, following Cannasouth's debut last June. Rua wi...

More Health

Southern Cross pays record 3.8 million claims
Law & Regulation

Southern Cross pays record 3.8 million claims

Rising demand and more frequent claims push up costs, directly impacting premiums.

John Anthony 30 Sep 2025
Fisher & Paykel Healthcare shares dip on new tariff fears
Markets

Fisher & Paykel Healthcare shares dip on new tariff fears

US Department of Commerce launched a “Section 232” on medical products.

Gregor Thompson 25 Sep 2025
NZer creates world's first waste-free drink
Retail

NZer creates world's first waste-free drink

They are tiny, concentrated balls of flavours and vitamins which dissolve in liquid.

Oceania forecasts sales lift as it targets debt
Property

Oceania forecasts sales lift as it targets debt

It said sales applications had lifted 23% between July and August.

Gregor Thompson 16 Sep 2025